Biocon gets CRL from USFDA for anti-cancer drug
Biotechnology firm Biocon today said the US health regulator has issued complete response letter (CRL) for proposed biosimilar Pegfilgrastim, indicated for use in the treatment…
Biotechnology firm Biocon today said the US health regulator has issued complete response letter (CRL) for proposed biosimilar Pegfilgrastim, indicated for use in the treatment…
While we are living longer, the burden of diseases, food sensitivities and allergies is certainly on the rise. According to a paper published in Interdisciplinary…
Dark chocolate nowadays popularly known as one of the best superfoods. If you nibble dark chocolate to satisfy a craving, you are also helping your…
Kenya Monday signed a multi-billion shilling deal with India to build East Africa’s biggest cancer hospital beginning early next year in a move that places…